We are live on
!
Find out more
HEC
Hudson Executive Capital Portfolio holdings
AUM
$151M
1-Year Est. Return
60.14%
This Fund
S&P 500
This Quarter
Est. Return
-1.84%
1 Year Est. Return
+60.14%
3 Year Est. Return
+143.92%
5 Year Est. Return
+104.85%
10 Year Est. Return
+677.02%
AUM
$1.25B
AUM Growth
-$82.1M
(-6.2%)
Cap. Flow
-$11.4M
Cap. Flow
% of AUM
-0.91%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
–
Increased
2
Reduced
1
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VRAY
ViewRay, Inc.
VRAY
|
+$968K |
| 2 |
AKYA
Akoya BioSciences
AKYA
|
+$525K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
eHealth
EHTH
|
+$12.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 69.37% |
| 2 | Healthcare | 17.98% |
| 3 | Technology | 7.01% |
Similar funds
SHF
CCM
DIG
BDS
MWA
WBCM
CAM
BA
Hudson Executive Capital's Q1 2022 Portfolio in Review
As of Q1 2022, Hudson Executive Capital held 10 positions worth $1.25B, down 6.2% from $1.33B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q1 2022: portfolio turnover was 0%. Hudson Executive Capital opened no new positions and made no exits, leaving the 10-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 69% of assets, up from 66% a quarter earlier, followed by Healthcare and Technology.
- Hudson Executive Capital added most to ViewRay, Inc. in Q1 2022, an estimated $968K increase.
- Hudson Executive Capital's biggest Q1 2022 reduction was eHealth, cutting an estimated $12.9M.
- Hudson Executive Capital's ten largest holdings make up 100% of its $1.25B portfolio in Q1 2022.
- Hudson Executive Capital opened 0 new positions and closed 0 in Q1 2022.
- Hudson Executive Capital's portfolio value fell 6.2% quarter-over-quarter to $1.25B.
Based on Hudson Executive Capital's 13F filing for Q1 2022, filed 16 May 2022.